Sihuan Pharmaceutical Holdings Group Ltd (460):企業の財務・戦略的SWOT分析

◆英語タイトル:Sihuan Pharmaceutical Holdings Group Ltd (460) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH189706FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥76,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥115,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Sihuan Pharmaceutical Holdings Group Ltd (Sihuan Pharmaceutical) is a pharmaceutical company that develops, manufactures and markets prescription drugs. The company offers products in the therapeutic areas of cardio-cerebral vascular system, central nervous system, metabolism, oncology and anti-infectives. Its cardio-cerebral vascular drug products comprise aoliankang, yeduojia, yuanzhijiu, oudimei, yimaining, qingtong, qu’ao, chuanqing, aogan and kelinao and anjieli. Sihuan Pharmaceutical offers other drugs such as luoanming, pojia, zhuo’ao and bi’ao and ren’ao. It works in collaboration with other pharmaceutical companies. The company sells its products through its distribution to network hospitals and medical institutions in Zhejiang, Guangdong and Henan. Sihuan Pharmaceutical is headquartered in Beijing City, Beijing, China.

Sihuan Pharmaceutical Holdings Group Ltd Key Recent Developments

Mar 11,2021: 2020-08-25 Sihuan Pharmaceutical Announces 2020 Interim Results Revenue from continuing operations and profit attributable to the company’s owners are RMB 1,054.5 million and RMB 170.5 million, respectively. See more
Aug 25,2020: Sihuan Pharmaceutical announces 2020 interim results revenue and profit attributable to owners of the company from continuing operations are RMB1,054.5 million and RMB170.5 million, respectively

This comprehensive SWOT profile of Sihuan Pharmaceutical Holdings Group Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Sihuan Pharmaceutical Holdings Group Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Sihuan Pharmaceutical Holdings Group Ltd – Key Information
Sihuan Pharmaceutical Holdings Group Ltd – Overview
Sihuan Pharmaceutical Holdings Group Ltd – Key Employees
Sihuan Pharmaceutical Holdings Group Ltd – Key Employee Biographies
Sihuan Pharmaceutical Holdings Group Ltd – Key Operational Heads
Sihuan Pharmaceutical Holdings Group Ltd – Major Products and Services
Sihuan Pharmaceutical Holdings Group Ltd – History
Sihuan Pharmaceutical Holdings Group Ltd – Company Statement
Sihuan Pharmaceutical Holdings Group Ltd – Locations And Subsidiaries
Sihuan Pharmaceutical Holdings Group Ltd
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Sihuan Pharmaceutical Holdings Group Ltd – Business Description
Sihuan Pharmaceutical Holdings Group Ltd – Corporate Strategy
Sihuan Pharmaceutical Holdings Group Ltd – SWOT Analysis
SWOT Analysis – Overview
Sihuan Pharmaceutical Holdings Group Ltd – Strengths
Sihuan Pharmaceutical Holdings Group Ltd – Weaknesses
Sihuan Pharmaceutical Holdings Group Ltd – Opportunities
Sihuan Pharmaceutical Holdings Group Ltd – Threats
Sihuan Pharmaceutical Holdings Group Ltd – Key Competitors

Section 3 – Company Financial Performance Charts

Sihuan Pharmaceutical Holdings Group Ltd – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Sihuan Pharmaceutical Holdings Group Ltd, Key Information
Sihuan Pharmaceutical Holdings Group Ltd, Key Ratios
Sihuan Pharmaceutical Holdings Group Ltd, Share Data
Sihuan Pharmaceutical Holdings Group Ltd, Major Products and Services
Sihuan Pharmaceutical Holdings Group Ltd, History
Sihuan Pharmaceutical Holdings Group Ltd, Key Employees
Sihuan Pharmaceutical Holdings Group Ltd, Key Employee Biographies
Sihuan Pharmaceutical Holdings Group Ltd, Key Operational Heads
Sihuan Pharmaceutical Holdings Group Ltd, Other Locations
Sihuan Pharmaceutical Holdings Group Ltd, Subsidiaries
Sihuan Pharmaceutical Holdings Group Ltd, Key Competitors
Sihuan Pharmaceutical Holdings Group Ltd, SWOT Analysis
Sihuan Pharmaceutical Holdings Group Ltd, Ratios based on current share price
Sihuan Pharmaceutical Holdings Group Ltd, Annual Ratios
Sihuan Pharmaceutical Holdings Group Ltd, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Sihuan Pharmaceutical Holdings Group Ltd (460):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Heinzel Holding GmbH:企業の戦略的SWOT分析
    Heinzel Holding GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Empresa Electricidad del Peru SA (ELECPBC1):企業の財務・戦略的SWOT分析
    Empresa Electricidad del Peru SA (ELECPBC1) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key streng …
  • Honkarakenne Oyj (HONBS):企業の財務・戦略的SWOT分析
    Honkarakenne Oyj (HONBS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Verseon Corp (VSN):企業の財務・戦略的SWOT分析
    Summary Verseon Corp (Verseon) is a pharmaceutical company that develops novel therapeutics. The company develops drug programs in the therapeutic areas of anticoagulation, diabetic macular edema, hereditary angioedema, and oncology. Its anticoagulation program develops oral anticoagulants for cardi …
  • Karlsruhe Institute of Technology:製薬・医療:M&Aディール及び事業提携情報
    Summary Karlsruhe Institute of Technology (KIT) is an educational service provider that offers research based scientific education. The institute offers research programs in the areas of biology, chemistry, and process engineering, mechanical and electrical engineering, physics and mathematics, natu …
  • Vingroup Joint Stock Co:企業の戦略・SWOT・財務情報
    Vingroup Joint Stock Co - Strategy, SWOT and Corporate Finance Report Summary Vingroup Joint Stock Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Foundation Radiology Group PC:製薬・医療:M&Aディール及び事業提携情報
    Summary Foundation Radiology Group PC (FRG) is a provider of radiology solutions. The company offers radiological services in areas of pediatric, neurology, mammography, musculoskeletal, PET and CT, cardiac CT and interventional radiology. It offers imaging solutions for the radiologists and systems …
  • Centers for Disease Control and Prevention-製薬・医療分野:企業M&A・提携分析
    Summary Centers for Disease Control and Prevention (CDC), a subsidiary of US Department of Health and Human Services is a public health institute that offers health, safety and security threat management solutions. The institute provides health information to fight diseases and support communities f …
  • Snam S.p.A. (SRG):電力:M&Aディール及び事業提携情報
    Summary Snam S.p.A. (Snam) is an integrated midstream energy company. The company, through its subsidiaries, carries out the regasification, transportation, storage and supply of natural gas. Snam Rete Gas, its subsidiary, transports natural gas; GNL Italia conducts regasification; and Stogit stores …
  • Enmax Corporation:企業の戦略的SWOT分析
    Enmax Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Central Securities Corp (CET):企業の財務・戦略的SWOT分析
    Summary Central Securities Corp (Central Securities) is a investment management company. The company offers investment management services and stock investment related services. It invests on convertible preferred stocks, bonds, preferred stocks, convertible bonds, warrants, options real estate and …
  • Corvia Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary Corvia Medical Inc (Corvia), formerly DC Devices Inc, is a medical device company that offers treatment of heart failure with structural heart devices. The company’s interatrial shunt device (IASD), a trans-catheter device and non-surgical medical device, is designed to treat diastolic heart …
  • Etam Developpement SCA:戦略・SWOT・企業財務分析
    Etam Developpement SCA - Strategy, SWOT and Corporate Finance Report Summary Etam Developpement SCA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Sudarshan Chemical Industries Ltd (SUDARSCHEM):企業の財務・戦略的SWOT分析
    Sudarshan Chemical Industries Ltd (SUDARSCHEM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key str …
  • Linklaters Llp:企業の戦略・SWOT・財務分析
    Linklaters Llp - Strategy, SWOT and Corporate Finance Report Summary Linklaters Llp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Ca Immobilien Anlagen Ag
    Ca Immobilien Anlagen Ag - Strategy, SWOT and Corporate Finance Report Summary Ca Immobilien Anlagen Ag - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • PNM Resources, Inc.:企業の戦略・SWOT・財務分析
    PNM Resources, Inc. - Strategy, SWOT and Corporate Finance Report Summary PNM Resources, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Taiwan Power Co Ltd:電力:M&Aディール及び事業提携情報
    Summary Taiwan Power Company Ltd (Taiwan Power) is an integrated state-owned electric utility that offers electricity generation, transmission and distribution services. The utility generates electricity through various fuel resources including thermal, coal, gas, cogeneration and renewable sources. …
  • Carnarvon Petroleum Ltd Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    Carnarvon Petroleum Ltd Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary Carnarvon Petroleum Ltd Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive inform …
  • Tetra Technologies, Inc.
    Tetra Technologies, Inc. - Strategy, SWOT and Corporate Finance Report Summary Tetra Technologies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆